Cationic nanovesicles have attracted considerable interest as effective carriers to improve the delivery of biologically active molecules into and through the skin. In this study, lipid-based nanovesicles containing three different cationic lysine-based surfactants were designed for topical administration. We used representative skin cell lines and in vitro assays to assess whether the cationic compounds modulate the toxic responses of these nanocarriers.
Introduction
Cationic lipid-based nanovesicles have been proposed as biocompatible drug delivery devices, with specific properties and able to overcome the barriers imposed by cell membranes [1] . Among various cationic substances, cationic amphiphile molecules have been successfully used in the composition of such carriers [1, 2] . Lipid-based devices have a broad spectrum of applications, one of which is the topical delivery of active ingredients, intensively studied in recent years [3, 4] . The inclusion of cationic compounds, such as biocompatible cationic amphiphiles, in the basic membrane of liposomes might be a promising approach to increasing the formulation's stability and its specificity for skin drug delivery. The development of new lipid-like molecules, such as cationic amphiphiles derived from lipoaminoacids [5, 6] , has become a major feature in the search for natural bioactive molecules that could be used in new drug delivery systems [7] . In this context, cationic lysine-based surfactants are a promissing group of amino acid-based amphiphiles that can be regarded as an alternative to conventional synthetic amphiphiles due to their multi-functionality and biodegradability, the renewable source of raw materials used during their synthesis and their low cytotoxic potential [5] .
The presence of charges at the vesicle surface may influence topical drug delivery. The skin surface bears a net negative charge [8] , which, therefore, favor the positively charged vesicles to increase the permeation rate of different model drugs through the skin [9, 10] . In contrast, some authors reported contradictory results, in which vesicles with negative charge have higher skin permeation [11, 12] . Although extensive studies have focused on the drug release and penetration properties of cationic vesicles, the potential toxic mechanisms of this kind of carrier have not been explained sufficiently. Some authors have studied the effect of structural properties of cationic vesicles on their cytotoxicity [13] , while others assessed the mechanisms of cell death induced by catanionic vesicles [14] . The search for reliable conditions to assess nanomaterials' safety is an emerging field that poses many interesting challenges.
Currently, there are no specific testing requirements for nanotechnology products and, therefore, researchers took liberal approaches to studying toxicity [15, 16] . Moreover, it is worth noting that, because of the expense of animal testing in toxicology and pressure from both the general public and government to develop alternatives to in vivo testing, in vitro cellbased models may be more attractive for preliminary testing of nanomaterials [17] . Here, we developed different formulations of cationic nanovesicles containing biocompatible lysinebased surfactants as surface modification agents, and screened in vitro toxicological assays both to understand better the potential health hazards of new nanomaterials designed for topical application and to create predictive toxicology approaches for testing nanotechnologybased products. We specifically studied whether the inclusion of cationic lysine-based surfactants, differing in the cationic charge position and in alkyl chain length, may determine the cytotoxic and phototoxic potential of nanovesicular systems and modulate molecular mechanisms such as inflammatory response in representative skin cell lines. Since there is a knowledge gap between the increasing development and use of nanomaterials and the prediction of possible health risks [18] , safety evaluation and greater understanding of nanomaterials' impact on human health are essential before any clinical application is explored.
Experimental

Chemicals and reagents
2,5-diphenyl-3,-(4,5-dimethyl-2-thiazolyl) tetrazolium bromide (MTT), neutral red (NR) dye, 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), cholesterol and dimethylsulphoxide (DMSO) were obtained from Sigma-Aldrich (St. Louis, MO, USA).
Dulbecco´s Modified Eagle´s Medium (DMEM), RPMI 1640 medium, fetal bovine serum (FBS), phosphate buffered saline (PBS), L-glutamine solution (200 mM), trypsin-EDTA solution (170,000 U/l trypsin and 0.2 g/l EDTA) and penicillin-streptomycin solution (10,000 U/ml penicillin and 10 mg/ml streptomycin) were purchased from Lonza (Verviers, Belgium).
The 75 cm 2 flasks and 96-well plates were obtained from TPP (Trasadingen, Switzerland). All other reagents were of analytical grade.
Surfactants included in the nanovesicular systems
Three new biocompatible amino acid-based surfactants derived from N ε or N α -acyl lysine methyl ester salts with one lysine as the cationic polar head (one cationic charge) and one alkyl chain were used as surface modification agents to prepare the cationic vesicular systems reported in this study: N ε -myristoyl lysine methyl ester (MKM) with one alkyl chain of 14 carbon atoms and one positive charge on the α-amino group of the lysine, N ε -palmitoyl lysine methyl ester (PKM) with one alkyl chain of 16 carbon atoms and one positive charge on the α-amino group of the lysine and N were 56:24:20 (30% cholesterol of the total lipid in the formulation). The organic solvent was removed under reduced pressure using a R-210 Rotary Evaporator (Buchi, Switzerland) at 50ºC for 60 min to form a homogeneous thin film. To remove residual traces of the organic solvents, the mixed film was freeze-dried (Christ Alpha 2-4 LD freeze-drying system, Martin
Christ, Germany) overnight. Ten ml of ultrapurified water was added to hydrate the film, and the resulting suspension was sonicated for 20 min at 60ºC in an Ultrasons-H ultrasonic bath (J.
P. Selecta, Spain) to promote the formation of uniform vesicles. The total final concentration of each mixed cationic nanovesicle was fixed at 2 mM.
Nanovesicle dispersions were purified by filtration using Vivaspin 2 centrifugal concentrator (PES membrane, 3,000 Da MWCO, Sartorius Stedim Biotech, Goettingen, Germany). The substance filtrated was used to determine the extent of incorporation of the cationic surfactants into the vesicles. The amount of unincorporated surfactant was assessed by high-performance liquid chromatography (HPLC), following the analytical method previously described [5] .
Nanovesicle characterization
The mean hydrodynamic size and the polydispersity index (PDI) of the cationic nanovesicles were determined at 25ºC by dynamic light scattering (DLS) using a Malvern
Zetasizer ZS (Malvern Instruments, Malvern, UK). The measurements were performed in ultrapurified water immediately after preparation (t = 0 h) and in cell culture medium with 5%
FBS at t = 0 h and after a 24 h incubation at 37ºC (t = 24 h). Each measurement was performed using at least three sets of at least ten runs.
The zeta potential (ZP) values of the nanovesicle formulations were assessed by determining the electrophoretic mobility of a particle with the Malvern Zetasizer ZS equipment. The measurements were performed in ultrapurified water and cell culture medium at 25ºC using at least three sets of at least 20 runs.
The morphology and size anlaysis of the vesicular systems were analysed by transmission electron microscopy (TEM) and the images were obtained with a Jeol JEM-1010 electron microscope (Jeol Ltd., Tokyo, Japan) operating at an acceleration voltage of 80 kV. A droplet (5 μl) of the vesicles dispersed in ultrapure water was placed on a carbon-coated copper grid, forming a thin liquid film. The negative staining of samples was obtained with a 2% (w/v) solution of phosphotungstate acid (pH 6.5, with KOH). The excess solution was removed by a filter paper and followed by thorough air-drying.
Cell cultures
The murine Swiss albino fibroblasts, 3T3, and the spontaneously immortalized human keratinocyte HaCaT cell lines were grown in DMEM medium (4.5 g/l glucose) supplemented by 10% (v/v) FBS, 2 mM L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin at 37ºC, 5% CO 2 . The 3T3 and HaCaT cells were routinely cultured in 75 cm 2 culture flasks and were trypsinized using trypsin-EDTA when the cells reached approximately 80% confluence.
The human monocytic leukemia cell line THP-1 was grown in RPMI 1640 medium supplemented by 10% (v/v) FBS, 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 50 μM 2-mercaptoethanol at 37ºC, 5% CO 2 . The three cell lines were obtained from Eucellbank (Universitat de Barcelona, Spain).
2.6. Cytocompatibility assays 3T3 (1 x 10 5 cell/ml) and HaCaT (7.5 x 10 4 cell/ml) cells were seeded into 96-well cell culture plates in 100 µl of complete culture medium. Cells were incubated for 24 h under 5% CO 2 at 37ºC and the medium was then replaced with 100 µl of fresh medium supplemented by 5% FBS containing the vesicular system dispersions in the 0.5 -100 μM concentration range.
THP-1 cells were seeded into 24-well plates at a density of 1 x 10 6 cell/ml and then treated with vesicle dispersions in the 1 -100 μM concentration range. The final volume in each well was 500 μl and the medium used contained 5% FBS. Each concentration was tested in triplicate and control cells were exposed to medium with 5% FBS only. The cell lines were exposed for 24 h to each nanovesicle treatment.
To determine whether the NVs interact with the viability assays, UV-visible absorbance measurements were carried out [19, 20] . NVs at 100 μM were suspended in DMEM medium (without FBS and phenol red) containing MTT (0.5 mg/ml) or NR (50 μg/ml) dyes. After 3 h incubation under cell culture conditions, the NVs were pelleted by ultracentrifugation, rinsed and extracted with DMSO or a solution containing 50% ethanol absolute and 1% acetic acid in distilled water for MTT and NR dyes, respectively. The extracted solution was transferred to a quartz cuvette and the absorbance read at 550 nm and at intervals from 300 to 700 nm on a Shimadzu UV-160A spectrophotometer (Shimadzu, Kyoto, Japan).
MTT assay
The MTT assay is based on the protocol first described by Mossmann [21] . In this assay, living cells reduce the yellow tetrazolium salt MTT to insoluble purple formazan crystals. After 24 h exposure of 3T3 and HaCaT cells to the various vesicular systems, the treatment-containing medium was removed, and 100 µl of MTT in PBS (5 mg/ml) diluted 1:10 in FBS-free medium without phenol red was then added. Plates were further incubated for 3 h, after which time the medium was removed. The purple formazan product was then dissolved by adding 100 µl of DMSO to each well. Plates were then placed in a microtitreplate shaker for 10 min at room temperature and the absorbance of the resulting solutions was measured at 550 nm using a Bio-Rad 550 microplate reader.
After 24 h incubation of THP-1 cells with the treatments, the plates were centrifuged and supernatants were collected and kept at -80ºC till subsequent analysis (see section 1.9).
Then, 300 μl of a MTT solution of 0.75 mg/ml was added to each well. Cells were incubated for 3 h at 37ºC, plates were then centrifuged, medium discarded and cells lysed in 250 μl/well of a mixture of HCl/isopropanol. 100 μl of the resulting solutions were transferred to a 96-well plate and the absorbance was read as described above. Cell viability was calculated as the percentage of tetrazolium salt reduction by viable cells on each sample against the untreated cell control (cells with medium only).
NRU assay
Based on the protocol described by Borenfreund and Puerner [22] , the NRU assay was performed following exposure to the nanovesicles. 3T3 and HaCaT cells were incubated for 3 h with NR dye solution (50 µg/ml) dissolved in medium without FBS and phenol red. Cells were then washed with PBS, followed by the addition of 100 µl of a solution containing 50%
ethanol absolute and 1% acetic acid in distilled water to extract the dye. Plates were gently shaken for 10 min to ensure complete dissolution. We then measured the absorbance of the Olympus, Japan). Images were digitised by an Olympus XC50 camera connected to Olympus cell^B computer software.
Phototoxicity assay
Cell lines 3T3 and HaCaT were used as in vitro models to predict cutaneous phototoxicity. Two plates were seeded with cells; one for irradiation (+UVA) and the other wrapped in foil and therefore non-irradiated (-UVA). The cells were treated with the various vesicle formulations, as described in section 2.6. After treatment application, the plates were pre-incubated for 1 h at 37°C in a humidified 5% CO 2 and then irradiated with a dose of 2.5 J/cm 2 UVA light. Following irradiation, the plates were incubated again under the same conditions to complete 24 h exposure. MTT and NRU endpoint assays were used to assess the phototoxic potential of the formulations. The phototoxic effect was evaluated by the OECD phototoxic validation test [23] , with some modifications. A photoirritation-factor (PIF) was calculated, using the following formula:
Based on the results, a test substance with a PIF < 2 predicts "no phototoxicity"; a PIF > 2 and < 5 predicts "probable phototoxicity" and a PIF > 5 predicts "phototoxicity". of the cell lysate determined by a commercial kit (Bio-Rad, Hercules, CA, USA) based on the dye-binding procedure of Bradford [24] . Cell viability was determined by the LDH leakage assay as described previously.
IL-8 release was assessed in cell-free supernatants after incubation of the various cationic vesicle formulations with THP-1 cells. The supernatants were colected directly from the cytotoxicity assay plates, centrifuged and stored at -80ºC until analysis.
Statistical analysis
All in vitro experiments were performed at least three times, using three replicate samples for each formulation concentration tested. Results are expressed as mean ± standard error of the mean (SEM). Statistical analyses used the Student's t-test or one-way analysis of variance (ANOVA) to determine the differences between the datasets, followed by Dunnett's post-hoc test for multiple comparisons using SPSS ® software (SPSS Inc., Chicago, IL, USA).
p < 0.05 and p < 0.005 were considered significant.
Results and discussion
Cationic lipid-based vesicles have attracted considerable interest because of their use as effective drug delivery systems [25, 26] . More specifically, these kinds of carriers have been studied to improve the delivery of biologically active molecules into and through the skin [10, 12] . Among a range of applications, cationic nanovesicles could be used in cosmetic formulations and epicutaneous drug release, because the addition of polar amphiphiles increases the likelihood of skin penetration [27] . In the present study, we provided new cationic nanocarriers as possible vehicles for dermal and transdermal applications. The cationic amphiphiles used as surface modification agents have biocompatible properties and can be considered much more suitable for practical applications than current commercial surfactant systems [28] . Furthermore, we showed previously that amphiphiles with the positive charge on the α-amino group of lysine (MKM and PKM) have pH-dependent membrane lytic activity [29, 30] . Some researchers have reported that the use of pH-sensitive lipid vesicles for skin delivery of biologically active molecules resulted in enhanced effects [31] .
Here experiments were performed to investigate the physicochemical parameters of the nanovesicles and, more particularly, to see how their composition affects their interaction with cells that are representative of the skin and play a key role in irritant, inflammatory and immunological reactions. The in vitro methods proposed here to assess the safety of new nanomaterials are adapted to nanoscale colloids. They are a direct extension of methods known for other macroscopic biomaterials or soluble drug toxicology assessments. However, since there are no defined protocols for assessing nanotoxicity [15, 16] , the use of the current assays to evaluate the toxic potential and the mechanisms involved is of great importance in determining structure/function relationships between nanomaterials and toxicity.
Characterization of cationic nanovesicles
Nanomaterial size and zeta potential are very important parameters in drug delivery applications. As keeping nanomaterials in solution for longer periods results in aggregation [32] , we prepared fresh formulations for each subsequent study to guarantee nanosized vesicles. Table 1 The TEM morphological analysis showed that all the cationic vesicle formulations displayed clear negative staining images with a roughly spherical shape (Fig. 1) . The nanovesicles containing the surfactants with the positive charge on the α-amino group of lysine (PKM and MKM) were in general much smaller (~ 20-50 nm) than those obtained by DLS. These differences were especially significant for the nanovesicles with MKM (Figs. 1a,   b ), while the formulations with PKM showed more heterogeneous size distribution (Fig. 1e, f ).
The mean hydrodynamic particle size measured by DLS did not capture the real population distribution of the nanovesicles observed by TEM. The latter's aggregate population was undetected even as a peak by DLS analysis. This disparity between DLS and TEM analysis, previously reported [32, 35, 36] , might be a result of the resolution limitations of DLS. DLS provides a scattered intensity-based size of a colloidal particle, and thus the mean diameter is biased towards larger vesicles, even though they may occupy a much smaller fraction of the vesicle population [35] . Moreover, these observed differences might be attributed to aggregation [32, 37] or to the swelling of the nanovesicles in the presence of water [36] . In contrast, the nanovesicles containing the surfactant MLM, which have the positive charge on the ε-amino group of lysine, did not show the same significant disparity between DLS and TEM analysis (Figs. 1c, d ). In general, the TEM images corroborated the mean size obtained by DLS. Moreover, TEM images also revealed the formation of a multilayered membrane in the vesicles containing the surfactant MLM (Figs. 1c, d ), while those containing the surfactants MKM and PKM showed unilamellar membranes in both presence and absence of cholesterol in the basic membrane (Figs. 1a, b, e, f) .
The HPLC analysis of the filtrated samples (obtained from the purification process performed to remove the unincorporated amount of surfactant) revealed that the cationic surfactants were highly incorporated into the formulations (from 75 to 99% incorporation).
( Table 1 ). It is noteworthy that the vesicles containing cholesterol have a lower degree of surfactant incorporation than those with DMPC only. Moreover, the formulations with the surfactant PKM have almost total incorporation of this compound into the nanovesicle. This observation was fully expected since, the longer the alkyl chain of a surfactant is, the greater is its tendency to incorporate into lipid-based vesicles due to its hydrophobicity [38] .
Cytocompatibility studies
The cytotoxic potential of new nanovesicles designed for biomedical application was evaluated on representative skin cells using established in vitro methods. HaCaT keratinocyte and 3T3 fibroblast cultures gave an appropriate in vitro model for skin irritation [39] , while the human monocytic leukemia cell line THP-1 is considered surrogate of cutaneous dendritic cells in in vitro skin sensitization studies [40] . The combination of different cell lines and cytotoxicity assays gives information concerning general and specific toxicological mechanisms [41] that could help in understanding the toxic response of nanomaterials.
All the formulations containing the surfactants showed, as expected, higher cytotoxicity than the vesicles formulated without surfactant (data not shown). The cationic charge of the vesicles is probably responsible for the initial binding to the surface membrane by ionic interaction with the negatively charged cell membrane [42] , which might enhanced the toxic effects of these formulations. Indeed, the cytotoxic effects observed showed many disparities between formulations that, in fact, depend on the surfactant, cell line and endpoint assay. The vesicles containing MKM and PKM (positive charge on the α-amino group of lysine) have a clear and dose-dependent decrease in MTT activity in the three cell lines studied after 24 h, while the NRU and LDH assays showed a significant decline in cell viability only at doses > 50 μM (Fig. 2) . In contrast, the vesicular systems containing MLM (positive charge on the ε-amino group of lysine) showed similar cytotoxic responses by the three endpoint assays. These differences are reflected by comparing the IC 50 values of the vesicles, as shown in Table 2 .
In studies of MTT and NR dye interactions with nanovesicles, we observed minimal interference with each dye. These data were proved by the UV-vis measurements (data not shown). Only the formulations containing PKM induced a slight increase in the MTT absorbance values at 550 nm. This might be due to a false positive reaction in which MTT was converted to formazan in the absence of cells. However, these small interferences did not result in further increases in cell viability with increasing concentration (false viability), which is in contrast to previous reported data for other types of nanomaterials [19, 20] . These data prove that these viability endpoints are suitable for the intended purpose.
A key finding of our research was that the structural characteristic of the surfactants included in the nanovesicular systems directly affect the toxicological effects of such nanomaterials. Firstly, the position of the cationic charge in the amphiphile molecule was critical in determining the sensitivity of the endpoint used to assess the formulation's cytotoxicity. On the one hand, the nanovesicles containing the compounds with the positive charge on the α-amino group of lysine (MKM and PKM) have greater cytotoxicity detected by
MTT than by NRU and LDH endpoints. On the other hand, the nanovesicles containing MLM
(with the positive charge on the ε-amino group of lysine) displayed in general the same level of cytotoxicity with the three endpoints. These effects might be due to a different interaction mechanism of the vesicular systems within cell as a function of the cationic charge position on the amphiphile included in them. The MTT assay is a measurement of cell metabolic activity within the mitochondrial compartment, while the NRU and LDH assays measure membrane integrity. NR dye diffuses through intact cell membranes to accumulate within lysosomes, while the LDH endpoint detects cells in the last stages of cell death [43] . Based on the mechanisms of cell damage detected by each cytotoxicity assay, our overall results suggest that the vesicles containing MKM and PKM interacted early with the mitochondrial compartment, first affecting cell metabolic activity, while the plasma membrane is affected in an lesser extent. The early interaction of these nanovesicles with the mitochondria might be due to their cell internalization before any damage to the cell membrane. The ability of these nanomaterials to be cell internalized was corroborated using the fluorophores nile red and calcein as drug models (unpublished results). Moreover, the pH-sensitive activity of MKM and PKM [29, 30] could favor this increased mitochondrial damage: the nanovesicles containing these compounds might have the ability to lysis the endosome membrane after cell internalization, enhancing, thus, their potencial toxicity in the cell cytoplasm (especially to the mitochondria). Finally, it is also worth noting that the length of the surfactant alkyl chain also affected the nanovesicles' cytotoxicity. Regardless of the cell line and endpoint used, the vesicular systems containing the amphiphile PKM were the most cytotoxic. Therefore, we can conclude that, the longer the alkyl chain of the surfactant is, the greater the cytotoxicity of the resulting vesicular system. In line with these findings, our previous studies revealed that the amphiphiles also displayed significant differences in their phospholipid bilayer-perturbing properties [29, 30] , corroborating that the interaction processes with cell membrane are directly dependent on surfactant structure.
Together with the disparities observed with different cytototoxic assays, we also found that each cell line used showed different sensitivity to the cationic nanovesicles.
Unfortunately, no clear conclusion was achieved about which cell was the most sensitive.
Although we have no explanation for these differences at present, these data showed cellspecific differences in cationic vesicle processing and toxicity. The results given are in line with previous studies [42, 44] , in which was reported that cytotoxic effects of particulate carrier systems differ, depending on the cell lines used, due to the innate nature, metabolic abilities (e.g. enzymes present) and capabilities of these cells. All in all, our results showed that the surfactants have a strong effect on the interaction of nanovesicles with the cells and, thus, on their cytotoxicity. These findings corroborated previous studies that found that the type and concentration of surfactant strongly affected the toxic responses of solid lipid nanoparticles [44] and also have a slighly effect on the cytotoxicity of lipoplex formulations [1, 2] .
Morphological analysis
Light microscopy analysis was used to view the effects of nanovesicles on the morphology of 3T3 cells after 24 h of incubation. Untreated control cells showed a wellspread and flattened morphology ( Table 2 ). In contrast, 3T3 cells treated with the IC 50 concentrations of the nanovesicles displayed prominent morphological changes, including rounding, reduced spreading and shrunken cells. These morphological changes corroborate and are directly attributed to the cytotoxic effects of each vesicular system.
Phototoxicity assessment
Keratinocytes and fibroblasts are considered biologically relevant targets for skin irritants and photoirritants [45] . We therefore chose HaCaT and 3T3 cells as model cell systems to study the cutaneous phototoxic potential of nanovesicles. No potential phototoxic effects were observed, with PIF values lower than 2 (non-phototoxic) in all cases (Fig. 3) . In general, the IC 50 values in irradiated (+UVA) and non-irradiated (-UVA) plates were similar to the HaCaT cells, and only the formulations containing the amphiphile MKM showed a significant increase (p < 0.005) in the toxic response after irradiation, as determined by the NRU assay. In contrast, more significant differences between (-UVA) and (+UVA) plates were observed with 3T3 cells, especially with the NRU assay. Although the MTT assay gave lower IC 50 values (for the formulations containing MKM and PKM) for the (+UVA) plates than the NRU assay did (as also found in the cytotoxicity assays, see section 3.2), the latter assay was more sensitive in detecting the UVA irradiation effects in both cell lines studied.
These results suggest that the nanovesicle treatment followed by UVA irradiation has a greater effect on the plasma membrane of the cells than on their metabolic activity. Furthermore, the results of nanovesicle phototoxicity revealed the different sensitivity of the two cell lines regardless of the endpoint used, with HaCaT cells being, in general, less sensitive to the phototoxic effects. This variability in the effects of photoirritants on human keratinocytes and 3T3 cells was previously demonstrated in the original phototoxicity validation study [46] and in the studies of other amino acid-based surfactants [47] . All these data indicate the importance of assessing specific effects with different endpoints in a variety of different cell types.
As also discussed above for the general cytotoxicity assays, it is worth mentioning that the structural features of the amphiphiles also affected the phototoxicity of the nanovesicles.
Vesicles containing MKM (positive charge on the α-amino group of lysine) had a significant phototoxic effect with both cell lines and endpoint assays, while those containing MLM (positive charge on the ε-amino group of lysine) had practically no phototoxicity in either cell line. Moreover, the length of the amphiphile alkyl chain also affected the phototoxicity of the formulations. Although the vesicles containing PKM (with 16 carbon atoms) were the most cytotoxic formulations, they showed lower phototoxic effects than those containing MKM (with 14 carbon atoms). Altogether, the results obtained showed that even though the formulations with MKM were the least cytotoxic in almost all conditions tested (see section 2.2), they displayed the highest potential phototoxicity of the nanovesicular systems. examine the capacity of this cell model to up-regulate cytokine (IL-8) production [48] . We found significantly higher IL-8 concentrations (652.14 ± 13.86 pg/ml, p < 0.005), while cell viability was 87.5% as detected by the MTT assay. THP-1 cells were chosen because they were proposed as an in vitro model able to produce and release the potent pro-inflammatory cytokine IL-8 [48, 49] . Therefore, this in vitro model is a promising tool for the screening of new nanomaterials with possible inflammatory response. IL-8 (Fig. 4) might be related to cell death, it is reasonable to consider cytokine release responses given by concentrations that displayed viability higher than 75% as significant [40, 49] . Therefore, we can reasonably consider as significant IL-8 releases those induced at concentrations equal to or lower than 2.5 μM and 5 μM for the formulations containing PKM and MKM, respectively, while no significant response can be attributed to the formulations containing MLM, as even a 10-fold higher concentration (50 μM, viability > 75%) did not induce IL-8 release. The IL-8 release induced by nanomaterials has also been studied in different cell lines and, in line with our findings, only slight or negligible inflammatory response due to increased levels of IL-8 was found [16, 50] .
Keratinocytes participate actively in inflammatory and immunological skin reactions [51] . The human keratinocyte HaCaT cell line was stimulated with SDS 20 μg/ml, as positive control, to confirm IL-1α up-regulation [52] . Under these conditions, we found significantly higher cell-associated IL-1α concentrations (239.12 ± 9.87 pg/mg protein, p < 0.005) with cell viability of 85.7% as detected by the LDH assay. Therefore, the combination of keratinocyte and cytokine production (IL-1α as a pro-inflammatory cytokine) offers a simplified in vitro model to evaluate the potential toxicity of new nanomaterial-based formulations with cutaneous applications. In this study, IL-1α production (both cell-associated and that released into extracellular media) was investigated in human keratinocytes following their exposure to nanovesicle formulations. The intracellular amount of IL-1α was standardized with the total cell protein content and the LDH assay was used as an indicator of cell viability. Moreover, the nanovesicles containing MLM were those that induced lower production of IL-1α, as also observed for IL-8 release. This means that the inflammatory response of the nanovesicles might also be directly related, as reported for the cytotoxic and phototoxic studies, to the position of the cationic charge of the amphiphile: the formulations containing the surfactant with the positive charge on the ε-amino group of the lysine have the least inflammatory potential. In the same way as described for the IL-8 and since the significant release at the highest concentrations might be related to cell death, the neosynthesis or release of IL-1α were not significant. All in all, and despite some significant responses found for IL-8
and IL-1α release in comparison with control cells, our results suggest that only a very slight inflammatory and allergenic effect was induced by nanovesicle formulations.
Conclusions
We demonstrated that the cytotoxicity of cationic nanovesicles differed between the three representative skin cell lines as well as when the in vitro endpoint varied, showing that the selected cell type and assay can affect the final outcome. Moreover, no potential phototoxic effect was induced by all nanovesicular systems, while only a slight inflammatory response occurred due to cytokine release. The formulations with MLM showed the lowest tendency to induce phototoxicity and inflammation. Overall, our findings showed that nanovesicle composition plays a primary role in the underlying toxicity. The cytotoxic responses of the nanovesicles varied especially as a function of the cationic charge position on the amphiphile included in them. Furthermore, the surfactant with the highest hydrophobicity tends to enhance the toxic potential of the formulations. All these findings suggest that differential toxicity according to vesicle composition could be an important concept when developing new nanomaterials for biomedical applications. In conclusion, the combination of all assays used in the present study offers an in-depth and comprehensive evaluation of the potentially toxic effects of nanomaterials. Due to their generally low toxicity, the nanovesicles containing MKM and MLM are especially recommended for topical administration.
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